Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Amneal Pharma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (358)

Date

2022 (49)
2021 (17)
2020 (22)
2019 (109)
2018 (78)
2017 (81)
2016 (1)
2015 (1)

Results for "[search-keyword]"

Search

Sponsor content

358 result(s) found, displaying 221 to 230

CANDESARTAN HCTZ AN 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
PREGABALIN AN pregabalin 25mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
PREGABALIN AN pregabalin 75mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
PREGABALIN AN pregabalin 150mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
PREGABALIN AN pregabalin 300mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
CELECOXIB AN Celecoxib 100 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
RALOXIFENE AN Raloxifene hydrochloride 60 mg tablets, blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
TELMISARTAN AN telmisartan 40mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
OLMESARTAN AN olmesartan medoxomil 10 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd
Olmesartan HCT AN 40/25 olmesartan medoxomil/hydrochlorothiazide 40/25 mg film coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Amneal Pharma Australia Pty Ltd

Pages

First page
Previous page
…
Page 19
Page 20
Page 21
Page 22
Current page 23
Page 24
Page 25
Page 26
Page 27
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.